欢迎来到天天文库
浏览记录
ID:33171111
大小:2.84 MB
页数:34页
时间:2019-02-21
《下腔静脉滤器植入联合置管溶栓治疗下肢深静脉血栓形成的临床研究》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库。
1、南昌大学硕士学位论文下腔静脉滤器植入联合置管溶栓治疗下肢深静脉血栓形成的临床研究姓名:罗启财申请学位级别:硕士专业:外科学指导教师:曾庆黎201206摘要摘要目的探讨下腔静脉滤器植入联合导管溶栓治疗下肢深静脉血栓形成(DVT)的临床疗效。方法选择2008年10月—20lO年8月在我院住院治疗的下肢深静脉血栓形成病人64例,其中治疗组32例,对照组32例,治疗组病人在数字减影血管造影技术(DSA)下植入下腔静脉滤器后,溶栓导管直接插入血栓内,持续注入尿激酶溶栓,介入术后配合低分子肝素抗凝治疗;对照组采用周身(周围静脉)抗凝、溶栓治疗。。结果、(1)治愈率:对照组治愈率是34
2、.4%(10/32),治疗组治愈率是87.5%(28/32),明显高于对照组(尸<0.05)。(2)治疗前后大小腿对应部位平均周径差:治疗前治疗组对应部位平均周径差较对照组差异无显著性,无统计学意义(P>O.05);治疗后治疗组对应部位平均周径差较对照组明显减小,差异具有明显的相关性,有统计学意义(尸<0.01)。(3)症状性肺动脉栓塞发生率:对照组是15.6%,治疗组0,较对照组减小,两组患者比较有显著性的差异(P<0.05)。(4)平均住院时间:对照组平均住院时间(12-1-3.6)天,治疗组平均住院时间(9±1.8)天,较对照组缩短,差异具有统计学意义(尸3、)。(5)治疗组深静脉通畅率为(87.5%),对照组深静脉通畅率为(34.4%),差异具有明显的相关性,有统计学意义伊4、cyofimplantationvenacavafilterthecombinedthecatheteringthrombolysistherapyinthetreatmentofdeepvenousthrombosisof10wer-limb.MethodsTotal64patientswithdeepvenousthrombosisweretreatedinmyhospitalfromoctober2008toauguest2010.Thepatientsweredividedintoexperimentgroup(32cases)andcontrolgroup(325、cases).TheexperimentgroupofwithDVTunderwentintheDSAimplantationvenacavafilters,intraluminalcathter-directedthrombolysiswithurokinaseinpactandcontinuousinfusion.Thecontrolgroupweretheatedf-romvenousthrombolysistherapy.ResultsFirst,Aftertreatment,thecurerateofthetreatmentgroupis87.5%(28/32)6、.thecontrolgroupwas34.4%(10/32),thedifferencewassignificant伊<0.05).Second,Twostudieshaveshownthatthecontrolgroup,symptomsofpulmonaryembolismincidenceis15.6%(5/32).thetreatmentgroupdoesnotappearonecasesofsymptomaticpulmonaryembolism(0/32),symptomaticpulmonaryembolismrateintreatmentgrouptha7、ninthecontrolgroupinsignificantlyreduced.Thetwogroupsofpatientshaveasignificantdifference(P
3、)。(5)治疗组深静脉通畅率为(87.5%),对照组深静脉通畅率为(34.4%),差异具有明显的相关性,有统计学意义伊4、cyofimplantationvenacavafilterthecombinedthecatheteringthrombolysistherapyinthetreatmentofdeepvenousthrombosisof10wer-limb.MethodsTotal64patientswithdeepvenousthrombosisweretreatedinmyhospitalfromoctober2008toauguest2010.Thepatientsweredividedintoexperimentgroup(32cases)andcontrolgroup(325、cases).TheexperimentgroupofwithDVTunderwentintheDSAimplantationvenacavafilters,intraluminalcathter-directedthrombolysiswithurokinaseinpactandcontinuousinfusion.Thecontrolgroupweretheatedf-romvenousthrombolysistherapy.ResultsFirst,Aftertreatment,thecurerateofthetreatmentgroupis87.5%(28/32)6、.thecontrolgroupwas34.4%(10/32),thedifferencewassignificant伊<0.05).Second,Twostudieshaveshownthatthecontrolgroup,symptomsofpulmonaryembolismincidenceis15.6%(5/32).thetreatmentgroupdoesnotappearonecasesofsymptomaticpulmonaryembolism(0/32),symptomaticpulmonaryembolismrateintreatmentgrouptha7、ninthecontrolgroupinsignificantlyreduced.Thetwogroupsofpatientshaveasignificantdifference(P
4、cyofimplantationvenacavafilterthecombinedthecatheteringthrombolysistherapyinthetreatmentofdeepvenousthrombosisof10wer-limb.MethodsTotal64patientswithdeepvenousthrombosisweretreatedinmyhospitalfromoctober2008toauguest2010.Thepatientsweredividedintoexperimentgroup(32cases)andcontrolgroup(32
5、cases).TheexperimentgroupofwithDVTunderwentintheDSAimplantationvenacavafilters,intraluminalcathter-directedthrombolysiswithurokinaseinpactandcontinuousinfusion.Thecontrolgroupweretheatedf-romvenousthrombolysistherapy.ResultsFirst,Aftertreatment,thecurerateofthetreatmentgroupis87.5%(28/32)
6、.thecontrolgroupwas34.4%(10/32),thedifferencewassignificant伊<0.05).Second,Twostudieshaveshownthatthecontrolgroup,symptomsofpulmonaryembolismincidenceis15.6%(5/32).thetreatmentgroupdoesnotappearonecasesofsymptomaticpulmonaryembolism(0/32),symptomaticpulmonaryembolismrateintreatmentgrouptha
7、ninthecontrolgroupinsignificantlyreduced.Thetwogroupsofpatientshaveasignificantdifference(P
此文档下载收益归作者所有